Targeted Genetics last week said that it has received written notice from the Nasdaq Stock Market that trading of its common stock has been suspended and that the exchange has delisted the shares.
Targeted Genetics added that it does not plan to appeal the ruling. Its common stock is now traded on the Over-The-Counter Bulletin Board.